Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Requirements of a Usable Scoring System for Risk Stratification in Patients With Coronary Artery Disease

  • Sung Soo Kim (Department of Internal Medicine and Cardiovascular Center, Chosun University Hospital, University of Chosun College of Medicine) ;
  • Hyun Kuk Kim (Department of Internal Medicine and Cardiovascular Center, Chosun University Hospital, University of Chosun College of Medicine)
  • Received : 2024.02.28
  • Accepted : 2024.03.05
  • Published : 2024.04.01
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Fuster V. The proliferation of scoring systems: trying to keep our heads out of the clouds. J Am Coll Cardiol 2017;69:1640-1. https://doi.org/10.1016/j.jacc.2017.02.017
  2. Kim HK, Jeong MH, Ahn Y, et al. Hospital discharge risk score system for the assessment of clinical outcomes in patients with acute myocardial infarction (Korea Acute Myocardial Infarction Registry [KAMIR] score). Am J Cardiol 2011;107:965-971.e1. https://doi.org/10.1016/j.amjcard.2010.11.018
  3. Lee SH, Kim HK, Jeong MH, et al. Practical guidance for P2Y12 inhibitors in acute myocardial infarction undergoing percutaneous coronary intervention. Eur Heart J Cardiovasc Pharmacother 2021;7:112-24. https://doi.org/10.1093/ehjcvp/pvaa005
  4. Song PS, Kim J, An SY, et al. The association of CHADS-P2A2RC risk score with clinical outcomes in patients taking P2Y12 inhibitor monotherapy after 3 months of dual antiplatelet therapy following percutaneous coronary intervention. Korean Circ J 2024;54:189-200. https://doi.org/10.4070/kcj.2023.0268
  5. Steensig K, Olesen KK, Madsen M, et al. A novel model for prediction of thromboembolic and cardiovascular events in patients without atrial fibrillation. Am J Cardiol 2020;131:40-8. https://doi.org/10.1016/j.amjcard.2020.06.031
  6. Mehta SR, Granger CB, Boden WE, et al. Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med 2009;360:2165-75. https://doi.org/10.1056/NEJMoa0807986
  7. Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J 2023;44:3720-826. https://doi.org/10.1093/eurheartj/ehad191
  8. Lee YJ, Suh Y, Kim JS, et al. Ticagrelor monotherapy after 3-month dual antiplatelet therapy in acute coronary syndrome by high bleeding risk: the subanalysis from the TICO trial. Korean Circ J 2022;52:324-37. https://doi.org/10.4070/kcj.2021.0321
  9. Park MW. Balancing between ischemic and bleeding risk in PCI patients with 'bi-risk'. Korean Circ J 2022;52:338-40. https://doi.org/10.4070/kcj.2021.0429